| Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors L Pérez-Alós, JJA Armenteros, JR Madsen, CB Hansen, I Jarlhelt, ... Nature communications 13 (1), 1614, 2022 | 146 | 2022 |
| SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals CB Hansen, I Jarlhelt, L Pérez-Alós, LH Landsy, M Loftager, A Rosbjerg, ... The Journal of Immunology 206 (1), 109-117, 2020 | 118 | 2020 |
| SARS-CoV-2 antibodies mediate complement and cellular driven inflammation I Jarlhelt, SK Nielsen, CXH Jahn, CB Hansen, L Pérez-Alós, A Rosbjerg, ... Frontiers in Immunology, 4612, 2021 | 53 | 2021 |
| SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain R Bayarri-Olmos, M Idorn, A Rosbjerg, L Pérez-Alós, CB Hansen, ... The Journal of Immunology, 2021 | 36 | 2021 |
| Humoral response to two doses of BNT162b2 vaccination in people with HIV LD Heftdal, AD Knudsen, SR Hamm, CB Hansen, DL Møller, ... Journal of internal medicine 291 (4), 513-518, 2022 | 35 | 2022 |
| Decline in Antibody Concentration Six Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls SR Hamm, DL Møller, L Pérez-Alós, CB Hansen, MM Pries-Heje, ... Frontiers in Immunology, 564, 2022 | 31* | 2022 |
| SARS-CoV-2 Natural Antibody Response Persists for at Least 12 Months in a Nationwide Study From the Faroe Islands MS Petersen, CB Hansen, MF Kristiansen, JP Fjallsbak, S Larsen, ... Open Forum Infectious Diseases 8 (8), ofab378, 2021 | 24 | 2021 |
| Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming CB Hansen, I Jarlhelt, RB Hasselbalch, SR Hamm, K Fogh, ... Journal of Internal Medicine, 2021 | 18 | 2021 |
| Development of a quantitative assay for the characterization of human collectin-11 (CL-11, CL-K1) R Bayarri-Olmos, N Kirketerp-Moller, L Pérez-Alós, K Skjodt, MO Skjoedt, ... Frontiers in immunology 9, 2238, 2018 | 17 | 2018 |
| Prediction of Respiratory Failure and Mortality in COVID-19 Patients Using Long Pentraxin PTX3 CB Hansen, H Sandholdt, MEE Møller, L Pérez-Alós, L Pedersen, ... Journal of Innate Immunity, 1-9, 2022 | 16 | 2022 |
| Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk L Pérez-Alós, CB Hansen, JJ Almagro Armenteros, JR Madsen, ... Nature Communications 14 (1), 5624, 2023 | 15 | 2023 |
| Factors influencing the immune response over 15 months after SARS‐CoV‐2 infection: A longitudinal population‐wide study in the Faroe Islands MS Petersen, L Pérez‐Alós, JJA Armenteros, CB Hansen, JP Fjallsbak, ... Journal of internal medicine 293 (1), 63-81, 2023 | 11 | 2023 |
| Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases ZB Harboe, SR Hamm, L Pérez-Alós, P Sivapalan, H Priemé, T Wilcke, ... BMJ Open Respiratory Research 9 (1), e001268, 2022 | 11 | 2022 |
| Lectin pathway enzyme MASP-2 and downstream complement activation in COVID-19 MP Götz, MO Skjoedt, R Bayarri-Olmos, CB Hansen, L Pérez-Alós, ... Journal of Innate Immunity 15 (1), 122-135, 2023 | 10 | 2023 |
| Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV … O Rezahosseini, SR Hamm, LD Heftdal, L Pérez-Alós, DL Møller, M Perch, ... Frontiers in Immunology 13, 8224, 2022 | 8 | 2022 |
| Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV–a prospective observational cohort study LD Heftdal, L Pérez-Alós, RB Hasselbalch, CB Hansen, SR Hamm, ... EBioMedicine 93, 2023 | 7 | 2023 |
| Comparison of induction methods for supersaturation: pH shift versus solvent shift J Plum, C Bavnhøj, H Palmelund, L Pérez-Alós, A Müllertz, T Rades International journal of pharmaceutics 573, 118862, 2020 | 7 | 2020 |
| Combining MAP-1: CD35 or MAP-1: CD55 fusion proteins with pattern-recognition molecules as novel targeted modulators of the complement cascade L Pérez-Alós, R Bayarri-Olmos, MO Skjoedt, P Garred The FASEB Journal 33 (11), 12723, 2019 | 6 | 2019 |
| Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial D Wimbury, M Muto, JS Bhachu, K Scionti, J Brown, K Molyneux, C Seikrit, ... Kidney International 105 (2), 381-388, 2024 | 4 | 2024 |
| Short-Lived Antibody-Mediated Saliva Immunity against SARS-CoV-2 after Vaccination JR Madsen, BE Holm, L Pérez-Alós, R Bayarri-Olmos, A Rosbjerg, K Fogh, ... Microbiology spectrum 11 (2), e04947-22, 2023 | 4 | 2023 |
Peter GarredProfessor of Clinical Molecular Medicine, University of CopenhagenVerified email at post5.tele.dk
